Medline ® Abstract for Reference 159
of 'Overview of neurologic complications of non-platinum cancer chemotherapy'
Thalidomide induced impotence in male hematology patients: a common but ignored complication?
Murphy PT, O'Donnell JR
Thalidomide has become an important agent in the treatment of myeloma. However, thalidomide induced erectile dysfunction is a serious complication which has received very little attention. In our hematology department, 6 out of 11 male patients developed erectile dysfunction (grade 3 in 5/6) within 4 weeks of starting thalidomide. Our results suggest that thalidomide induced impotence is a common complication in male hematology patients.